Juliana Bue‐Valleskey

The role of neuropeptide Y in the antiobesity action of the obese gene product

Thomas W. Stephens, Margret B. Basinski, Pamela K. Bristow et al. · Nature · 1995 · 1.5K citations

Obesity, Metabolic Syndrome, Obese Gene Product +15

Non‐alcoholic fatty liver disease ( <scp>NAFLD</scp> ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes

Kenneth Cusi, Arun J. Sanyal, Shuyu Zhang et al. · Diabetes Obesity and Metabolism · 2017 · 180 citations

Mathematical models of diabetes progression

Andrea De Gaetano, Thomas A. Hardy, Benoît Beck et al. · American Journal of Physiology-Endocrinology and Metabolism · 2008 · 110 citations

Insulin Resistance, Diabetes Management, Body Composition +12

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week <scp>PRONTO‐T1D</scp> study

Leslie J. Klaff, Dachuang Cao, Mary Anne Dellva et al. · Diabetes Obesity and Metabolism · 2020 · 89 citations · Full text

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

John B. Buse, Helena W. Rodbard, Carlos Trescolí Serrano et al. · Diabetes Care · 2015 · 81 citations · Full text